Therefore, these HaCaT in vitro models exhibit the predicted signaling alterations expected by EGFR, RAS, and PI3K pathway activation without the complexity introduced by the broader genetic heterogeneity evident within the landscape of cancer cell lines or human tumors. This evidence concerns the gene PIK3CA and cancer.